Beyond neurotransmitter dysregulation, indoleamine 2,3-dioxygenase also modulates the tumor microenvironment by suppressing CD8+ tumor-infiltrating lymphocytes and promoting cancer cell survival, proliferation and invasion (61). Here, IDO2 is linked to cancer.